After 24 years, I will be honored to work with #RobertKennedyJr and the #Trump administration to bring accountability back to our healthcare markets.
#MedicalSupplyChain #GPOs #HHS #Medica2024 #DOJ #GOP #ElonMusk #DonaldTrump
Samuel Lipari created the business model for a web-based health system wide source of supply and commissioned the first working health system supply enterprise software system in 2001.
Lipari and his consultants at Lipari’s expense exposed the artificial inflation scheme of the hospital supply GPO’s, their monopolization and inflation scheme to hospitals in a series of hearings before the US Senate Judicial Committee Subcommittee on Antitrust and in litigation against US Bancorp and the three dominant hospital supply GPOs for their monopolization of the hospital supply market that lasted 15 years.
As a result of reforms provided evidence for and that Lipari substantially contributed to, a class action shareholder Racketeer Influenced and Corrupt Organization suit resulted in a settlement by the wrongdoers’ where the shareholders took over the private placement merger of the web- based supply business Neoforma, Inc. that had been co-opted and compromised by the monopolists. And, US Bancorp divested itself of Piper Jaffray at a loss of $600,000,000 (six hundred million dollars) in an uncompensated spin off to its shareholders to address the conflicts of interest exposed where the bank had been caught targeting the customers (medical device and supply manufacturers) that paid for investment research by US Bancorp Piper Jaffray and then conspiring to defraud those same customers’ investments through direct actions to further the hospital supply monopolies.
Finally, the three dominant hospital supply GPO cartels sued by Lipari, Novation LLC, VHA Inc., and the University Health System Consortium have lost their monopoly of the hospital supply cartel.
As a result of the senate testimony against the monopolization practices of the hospital supply GPOs to artificially inflate costs to hospital, the US Senate Judiciary Committee amended the False Claims Act (the “FCA”) when Congress passed the Fraud Enforcement and Recovery Act (“FERA”), and passed the Patient Protection and Affordable Care Act (“PPACA) that changed to the FCA in the health care sector so that indirect federal fund recipients including hospital supply GPOs would be liable for the artificial hospital supply cost inflation fraud detailed in Lipari’s consultant testimony and litigation.
Samuel Lipari has personally commissioned and built a new fully functional turn key enterprise suite of web-based commerce and enterprise tools to interface with existing ecommerce platforms and aggregate healthcare suppliers that support the market share among health systems and other hospital supply business customers projected by healthcare economists in an unmonopolized market.
https://lnkd.in/dfWAjAgZ
